Enteric diseases or gastrointestinal infections are caused by a range of microbes comprising bacteria, parasites, and viruses, primarily when they enter the body via the mouth. Numerous microbes responsible for enteric diseases are salmonella, rotavirus, C. difficile, vibrio, campylobacter, shigella, and norovirus. These diseases may have mild or severe symptoms including bloody diarrhea, stool containing blood or pus, weight loss, fever, and abdominal cramps. To reduce the complications, enteric diseases have to be diagnosed early.

The global enteric disease testing market is segmented on the basis of geography and type of disease. Based on geography, the global enteric disease testing market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2012, in terms of growth and potential, Asia Pacific accounted for more than 50% of the global enteric disease testing market.

Get Free Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1258

Factors such as the rising awareness, high occurrence of enteric diseases, and the inception of quick diagnostic tests are expected to propel the Asia Pacific enteric disease testing market in the next few years. The high level of consumer awareness is expected to propel the North America enteric disease testing market in the years to come. Some of the leading players in the global enteric disease testing market are DiaSorin, Alere, Meridian Bioscience, Cepheid, and Biomerica.

By type of disease, the global enteric disease testing market is classified into bacterial enteric disease testing, viral enteric disease testing, and parasitic enteric disease testing. The bacterial enteric disease testing segment is sub-segmented into C. difficile infection, cholera, E. coli infection, campylobacteriosis, and others. Earlier, the diagnosis of enteric diseases depended on culture results of stool samples. However, today, the trend is shifting towards other diagnostic methods due to the many limitations connected with culture tests.

High cost and the requirement for sophisticated laboratory equipment, labor, and skilled personnel are some of the drawbacks related to culture tests. In many developed regions, PCR-based diagnostic procedures are recommended to test enteric diseases as they offer high specificity and sensitivity and are rapid, accurate, and easy to manage. 

The global enteric disease testing market is expected to be hampered by factors such as the growing occurrence of mild and asymptomatic diseases and lack of awareness. However, the global enteric disease testing market is expected to register considerable growth due to the rising opportunities in molecular-diagnostics-based enteric disease testing and the growing opportunities in developing nations.

Browse Full Research Report: http://www.transparencymarketresearch.com/enteric-disease-testing-market.html

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.